All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Improving outcomes for people of color with chronic plaque psoriasis including scalp involvement
with Paolo Gisondi, Andrew Alexis, and Mona Shahriari
Thursday, February 6, 2025
16:00-17:00 GMT
This independent educational activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. All content is developed independently by the faculty. The funder is allowed no influence on the content.
The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB and Bristol Myers Squibb: For educational content and news updates.
Alice GottliebSteering Committee Member
Alice Gottlieb is a Clinical Professor of Dermatology at the Icahn School Of Medicine at Mount Sinai, Union Square, New York, US. She is triple-boarded in dermatology, rheumatology, and internal medicine and has a PhD in immunology From from The Rockefeller University.
Professor Gottlieb founded the Dermatology Residency Program at Tufts Medical Center and the Dermatology Division at UMDNJ-Robert Wood Johnson Medical School. She is also the founder and president of the IDEOM (International Dermatology Outcomes Measures) group. Throughout her career, Gottlieb has focused on the pathogenesis and treatment of psoriasis and psoriatic arthritis, and was the first to publish a study that demonstrated the efficacy of TNF blockers as monotherapy in psoriasis, leading to TNF blockers being approved for use and resulting in significant changes to the way psoriasis is treated.